SCHEMBL7182847

SCHEMBL7182847

CCP(=O)(C(=O)c1c(C)cccc1Cl)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 1/20 0.42
ITGB1 P05556 7/20 0.41
ITGA4 P13612 7/20 0.41
ITGA2 P17301 1/20 0.41
ITGB7 P26010 1/20 0.41
TRPM4 Q8TD43 1/20 0.41
FABP3 P05413 1/20 0.39
FABP4 P15090 1/20 0.39
ITGB2 P05107 1/20 0.38
ICAM1 P05362 1/20 0.38
ITGAL P20701 1/20 0.38
GAA P10253 3/20 0.38
MAPT P10636 1/20 0.38
ALDH2 P05091 1/20 0.37
UTS2R Q9UKP6 1/20 0.37
GPR52 Q9Y2T5 1/20 0.37
KMT2A Q03164 2/20 0.36
PTGS2 P35354 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7182200 0.91 ALDH1A1 (0.40) TYK2GAAMAPTKMT2AMEN1
SCHEMBL7186873 0.90 ALDH1A1 (0.41) GAAGPR52KMT2AMEN1ALDH1A1
SCHEMBL7183540 0.89 TYK2 (0.40) TYK2ITGB1ITGA4ITGA2ITGB7
SCHEMBL7187039 0.87 PLK1 (0.39) TYK2ITGB1ITGA4ITGA2ITGB7
SCHEMBL7186808 0.86 ITGB1 (0.42) TYK2ITGB1ITGA4ITGA2ITGB7
SCHEMBL7177040 0.85 PLK1 (0.41) TYK2ITGB1ITGA4ITGA2ITGB7
SCHEMBL7178218 0.85 ITGB1 (0.41) TYK2ITGB1ITGA4ITGA2ITGB7
SCHEMBL7180741 0.84 PLK1 (0.42) TYK2ITGB1ITGA4ITGA2ITGB7
SCHEMBL7189449 0.84 PLK1 (0.42) TYK2ITGB1ITGA4ITGA2ITGB7
SCHEMBL7182663 0.84 PLK1 (0.42) TYK2ITGB1ITGA4ITGA2ITGB7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 TYK2 1285/4885ITGB1 2786/4885ITGA4 3521/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 TYK2 1333/4885ITGB1 3321/4885ITGA4 3643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.